000 | 01165 a2200361 4500 | ||
---|---|---|---|
005 | 20250512034129.0 | ||
264 | 0 | _c19861117 | |
008 | 198611s 0 0 eng d | ||
022 | _a0308-051X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMondal, B K | |
245 | 0 | 0 |
_aParkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy. _h[electronic resource] |
260 |
_bPharmatherapeutica _c1986 |
||
300 |
_a571-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBenserazide _xadverse effects |
650 | 0 | 4 |
_aBromocriptine _xtherapeutic use |
650 | 0 | 4 |
_aConfusion _xchemically induced |
650 | 0 | 4 |
_aDrug Combinations _xadverse effects |
650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xetiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrazines _xtherapeutic use |
650 | 0 | 4 |
_aLevodopa _xadverse effects |
650 | 0 | 4 | _aLong-Term Care |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
700 | 1 | _aMondal, K N | |
773 | 0 |
_tPharmatherapeutica _gvol. 4 _gno. 9 _gp. 571-6 |
|
999 |
_c3099839 _d3099839 |